News
Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...
The demand for the widely used cancer drug Taxol is increasing, but it's difficult and expensive to produce because it hasn't been possible to do it biosynthetically. Until now, that is. Researchers ...
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how the company is delivering ...
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...
FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to ...
Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices Medicare will pay for pharmaceuticals.
BENGALURU (Reuters) -U.S.-based Waters Corp, which makes medical equipment used in clinical testing, has seen a spurt in ...
Covid-19 changed the trajectory of a small vaccine venture. Now, its researchers hope to develop new mRNA jabs for even more ...
COPENHAGEN (Reuters) -Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule medicines for obesity, type 2 diabetes and other ...
The FDA did not respond to a request for comment. U.S. Health Secretary Robert F. Kennedy Jr. has said that the agency's ...
Discover Fortrea Holdings Inc.'s Q1 2025 earnings insights, including reaffirmed guidance, cost-saving initiatives, and biotech pipeline growth amid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results